Endocrine Gland Neoplasms  >>  oxaliplatin  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
oxaliplatin / Generic mfg.
NCT00448838: Cetuximab, Gemcitabine, and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Completed
N/A
42
US
Cetuximab, C-225, Gemcitabine Hydrochloride, Gemcitabine HCl, Oxaliplatin
University of Miami
Pancreatic Cancer
08/07
03/11
NCT01760694: Multi-Modality Therapy for Untreated Patients With Resectable or Marginally Resectable Pancreatic Cancer

Terminated
N/A
6
US
Multi-Modality; IORT, Surgery, Radiation, Chemotherapy, Intraoperative Radiation Therapy (IORT), Chemotherapy: FOLFIRINOX, Oxaliplatin, Irinotecan, 5-FU, Leucovorin, Surgery: Resectable or Marginally Resectable
Southwestern Regional Medical Center
Pancreatic Cancer
07/14
07/14
NCT01209962: A Pilot Study of Diffusion MRI in the Assessment of Pancreatic Tumor Response

Completed
N/A
20
US
University of Michigan Rogel Cancer Center
Pancreatic Cancer
05/15
05/15

Download Options